Abstract:Sphingosine kinase (SK) catalyzes the formation of sphingosine 1-phosphate (S1P), a lipid messenger that plays an important role in a variety of mammalian cell processes, including inhibition of apoptosis and stimulation of cell proliferation. Basal levels of SIP in cells are generally low but can increase rapidly when cells are exposed to various agonists through rapid and transient activation of SK activity. To date, elucidation of the exact signaling pathways affected by these elevated S1P levels has relied on the use of SK inhibitors that are known to have direct effects on other enzymes in the cell. Furthermore, these inhibitors block basal SK activity, which is thought to have a housekeeping function in the cell. To produce a specific inhibitor of SK activation we sought to generate a catalytically inactive, dominant-negative SK. This was accomplished by site-directed mutagenesis of Gly(82) to Asp of the human SK, a residue identified through sequence similarity to the putative catalytic domain of diacylglycerol kinase. This mutant had no detectable SK activity when expressed at high levels in HEK293T cells. Activation of endogenous SK activity by tumor necrosis factor-alpha (TNF alpha), interleukin-lp, and phorbol esters in HEK293T cells was blocked by expression of this inactive sphingosine kinase (hSK(G82D)), Basal SK activity was unaffected by expression of hSR(G82D). Expression of hSK(G82D) had no effect on TNF alpha -induced activation of protein kinase C and sphingomyelinase activities. Thus, hSK(G82D) acts as a specific dominant-negative SK to block SK activation. This discovery provides a powerful tool for the elucidation of the exact signaling pathways affected by elevated S1P levels following SK activation. To this end we have employed the dominant-negative SK to demonstrate that TNF alpha activation of extracellular signal-regulated kinases 1 and 2 (ERK1,2) is dependent on SK activation.

Post-translational regulation of sphingosine kinases

The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy

Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. Obeid

Regulation and function of sphingosine kinase 2 in diseases.

Phosphorylation-dependent Translocation of Sphingosine Kinase to the Plasma Membrane Drives Its Oncogenic Signalling

A new model for regulation of sphingosine kinase 1 translocation to the plasma membrane in breast cancer cells

Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy

Recent advances in the role of sphingosine 1‐phosphate in cancer

Human Sphingosine Kinase: Purification, Molecular Cloning and Characterization of the Native and Recombinant Enzymes

Targeting sphingosine 1-phosphate and sphingosine kinases in pancreatic cancer: mechanisms and therapeutic potential

Sphingosine Kinase 1 Signaling in Breast Cancer: A Potential Target to Tackle Breast Cancer Stem Cells

Sphingosine kinase 1 isoform-specific interactions in breast cancer.

Role of Sphingosine-1-Phosphate Signaling Pathway in Pancreatic Diseases

An Oncogenic Role of Sphingosine Kinase

Sphingosine Kinase-1 Enhances Endothelial Cell Survival Through a PECAM-1–dependent Activation of PI-3K/Akt and Regulation of Bcl-2 Family Members

Regulation of cellular and systemic sphingolipid homeostasis

Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.

Expression of A Catalytically Inactive Sphingosine Kinase Mutant Blocks Agonist-Induced Sphingosine Kinase Activation - A Dominant-Negative Sphingosine Kinase

Sphingosine 1-phosphate: Lipid signaling in pathology and therapy

The sphingosine kinase 2 inhibitors ABC294640 and K145 elevate (dihydro)sphingosine 1-phosphate levels in various cells

Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming